{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:14:38Z","timestamp":1740179678471,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006673","name":"Fonds L\u00e9on Fredericq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s41999-021-00563-8","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T02:47:45Z","timestamp":1632538065000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients\u2019 preferences for quality-of-life aspects in sarcopenia: a best\u2013worst scaling study"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-0224","authenticated-orcid":false,"given":"Anton","family":"Geerinck","sequence":"first","affiliation":[]},{"given":"M\u00e9d\u00e9a","family":"Locquet","sequence":"additional","affiliation":[]},{"given":"Micka\u00ebl","family":"Hiligsmann","sequence":"additional","affiliation":[]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[]},{"given":"Charlotte","family":"Beaudart","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"563_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169548","volume":"12","author":"C Beaudart","year":"2017","unstructured":"Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruy\u00e8re O (2017) Health outcomes of sarcopenia: a systematic seview and meta-analysis. PLoS ONE 12:e0169548","journal-title":"PLoS ONE"},{"key":"563_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.maturitas.2018.11.003","volume":"119","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re O, Beaudart C, Ethgen O, Reginster JY, Locquet M (2019) The health economics burden of sarcopenia: a systematic review. Maturitas 119:61\u201369. https:\/\/doi.org\/10.1016\/j.maturitas.2018.11.003","journal-title":"Maturitas"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.14283\/jfa.2016.93","volume":"5","author":"T Woo","year":"2016","unstructured":"Woo T, Yu S, Visvanathan R (2016) Systematic literature review on the relationship between biomarkers of sarcopenia and quality of life in older people. J Frailty Aging 5:88\u201399. https:\/\/doi.org\/10.14283\/jfa.2016.93","journal-title":"J Frailty Aging"},{"key":"563_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01663-4","author":"JY Reginster","year":"2020","unstructured":"Reginster JY, Beaudart C, Al-Daghri N, Avouac B, Bauer J, Bere N et al (2020) Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-020-01663-4","journal-title":"Aging Clin Exp Res"},{"key":"563_CR5","volume-title":"Value and use of patient-reported outcomes (PROs) in assessing effects of medical devices","author":"Food and Drug Administration","year":"2017","unstructured":"Food and Drug Administration (2017) Value and use of patient-reported outcomes (PROs) in assessing effects of medical devices. FAO, Rome"},{"key":"563_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ageing\/afv133","volume":"44","author":"C Beaudart","year":"2015","unstructured":"Beaudart C, Biver E, Reginster J-YJ-Y, Rizzoli R, Rolland Y, Bautmans I et al (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44:960\u2013966. https:\/\/doi.org\/10.1093\/ageing\/afv133","journal-title":"Age Ageing"},{"key":"563_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jcsm.12149","volume":"8","author":"C Beaudart","year":"2017","unstructured":"Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I et al (2017) Validation of the SarQoL\u00ae, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle 8:238\u2013244. https:\/\/doi.org\/10.1002\/jcsm.12149","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"563_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-021-02823-3","author":"A Geerinck","year":"2021","unstructured":"Geerinck A, Beaudart C, Reginster J-Y, Locquet M, Monseur C, Gillain S et al (2021) Development and validation of a short version of the Sarcopenia Quality of Life questionnaire\u202f: the SF-SarQoL. Qual Life Res. https:\/\/doi.org\/10.1007\/s11136-021-02823-3","journal-title":"Qual Life Res"},{"key":"563_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40520-018-1098-3","volume":"31","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Pinto D, Dennison E, Al-Daghri N, Beaudart C, Branco J et al (2019) Patients\u2019 preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clin Exp Res 31:1\u20133. https:\/\/doi.org\/10.1007\/s40520-018-1098-3","journal-title":"Aging Clin Exp Res"},{"key":"563_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40273-016-0429-5","volume":"34","author":"KL Cheung","year":"2016","unstructured":"Cheung KL, Wijnen B, Hollin I, Janssen E, Bridges J, Evers S et al (2016) Using best\u2013worst scaling to investigate preferences in health care. Pharmacoeconomics 34:1195\u20131209. https:\/\/doi.org\/10.1007\/s40273-016-0429-5","journal-title":"Pharmacoeconomics"},{"key":"563_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jamda.2019.08.026","volume":"21","author":"M Hiligsmann","year":"2020","unstructured":"Hiligsmann M, Beaudart C, Bruy\u00e8re O, Biver E, Bauer J, Cruz-Jentoft AJ et al (2020) Outcome priorities for older persons with sarcopenia. J Am Med Dir Assoc 21:267-271.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.08.026","journal-title":"J Am Med Dir Assoc"},{"key":"563_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jamda.2019.09.004","volume":"21","author":"C Beaudart","year":"2020","unstructured":"Beaudart C, Bruy\u00e8re O, Cruz-Jentoft AJ, Vaquero-Pinto MN, Locquet M, Bauer J et al (2020) Patient\u2019s engagement in the identification of critical outcomes in sarcopenia. J Am Med Dir Assoc 21:284\u2013286. https:\/\/doi.org\/10.1016\/j.jamda.2019.09.004","journal-title":"J Am Med Dir Assoc"},{"key":"563_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhealeco.2006.04.002","volume":"26","author":"TN Flynn","year":"2007","unstructured":"Flynn TN, Louviere JJ, Peters TJ, Coast J (2007) Best-worst scaling: What it can do for health care research and how to do it. J Health Econ 26:171\u2013189. https:\/\/doi.org\/10.1016\/j.jhealeco.2006.04.002","journal-title":"J Health Econ"},{"key":"563_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exger.2015.05.003","volume":"69","author":"C Beaudart","year":"2015","unstructured":"Beaudart C, Reginster JY, Petermans J, Gillain S, Quabron A, Locquet M et al (2015) Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 69:103\u2013110","journal-title":"Exp Gerontol"},{"key":"563_CR15","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107337855","volume-title":"Best-worst scaling: theory, methods and applications","author":"JJ Louvi\u00e8re","year":"2015","unstructured":"Louvi\u00e8re JJ, Flynn TN, Marley AAJ (2015) Best-worst scaling: theory, methods and applications. Cambridge University Press, Cambridge"},{"key":"563_CR16","unstructured":"Sawtooth Software (2020) Lighthouse Studio Manual. https:\/\/www.sawtoothsoftware.com\/help\/lighthouse-studio\/manual\/index.html?hid_web_maxdiff_numberofsets.html. Accessed 09 Nov 2020"},{"key":"563_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"563_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7:28\u201336. https:\/\/doi.org\/10.1002\/jcsm.12048","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"563_CR19","unstructured":"Sawtooth Software (2021) Identifying bad respondents: fit statistic and identifying random responders. https:\/\/sawtoothsoftware.com\/help\/lighthouse-studio\/manual\/hid_web_maxdiff_badrespondents.html. Accessed 20 Sept 2021"},{"key":"563_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4135\/9781412983648","volume":"17","author":"MJ Norusis","year":"2011","unstructured":"Norusis MJ (2011) IBM SPSS statistics 19 statistical procedures companion. Clust Anal Chapter 17:361\u2013391. https:\/\/doi.org\/10.4135\/9781412983648","journal-title":"Clust Anal Chapter"},{"key":"563_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316801","volume-title":"Finding groups in data: an introduction to cluster analysis","author":"L Kaufman","year":"1990","unstructured":"Kaufman L, Rousseeuw P (1990) Finding groups in data: an introduction to cluster analysis. Wiley-Interscience, New Jersey"},{"key":"563_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213263","author":"KM Van Leeuwen","year":"2019","unstructured":"Van Leeuwen KM, Van Loon MS, Van Nes FA, Bosmans JE, De Veti HCW, Ket JCF et al (2019) What does quality of life mean to older adults? A thematic synthesis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0213263","journal-title":"PLoS ONE"},{"key":"563_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ageing\/afq156","volume":"40","author":"AE Molzahn","year":"2011","unstructured":"Molzahn AE, Kalfoss M, Makaroff KS, Skevington SM (2011) Comparing the importance of different aspects of quality of life to older adults across diverse cultures. Age Ageing 40:192\u2013199. https:\/\/doi.org\/10.1093\/ageing\/afq156","journal-title":"Age Ageing"},{"key":"563_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11136-016-1391-6","volume":"26","author":"J Ratcliffe","year":"2017","unstructured":"Ratcliffe J, Lancsar E, Flint T, Kaambwa B, Walker R, Lewin G et al (2017) Does one size fit all? Assessing the preferences of older and younger people for attributes of quality of life. Qual Life Res 26:299\u2013309. https:\/\/doi.org\/10.1007\/s11136-016-1391-6","journal-title":"Qual Life Res"},{"key":"563_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0189687","volume":"13","author":"EJ Uy","year":"2018","unstructured":"Uy EJ, Bautista DC, Xin X, Cheung YB, Thio ST, Thumboo J (2018) Using best-worst scaling choice experiments to elicit the most important domains of health for health-related quality of life in Singapore. PLoS ONE 13:1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0189687","journal-title":"PLoS ONE"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-021-00563-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-021-00563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T12:08:39Z","timestamp":1650456519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-021-00563-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1007\/s41999-021-00563-8","relation":{},"ISSN":["1878-7657"],"issn-type":[{"type":"electronic","value":"1878-7657"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CB, J-YR & OB are shareholders of SarQoL sprl, a spin-off of the University of Li\u00e8ge. All other authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received the approval of the Ethics Committee of the University Teaching Hospital of Li\u00e8ge in an amendment approved on 19\/12\/2019 to research protocol n\u00b0 2012\/277.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}